Sandra Gurrola - Jun 21, 2023 Form 4 Insider Report for Eterna Therapeutics Inc. (ERNA)

Role
Vice President of Finance
Signature
/s/ Sandra Gurrola
Stock symbol
ERNA
Transactions as of
Jun 21, 2023
Transactions value $
-$444
Form type
4
Date filed
6/23/2023, 08:30 PM
Previous filing
Jun 23, 2022
Next filing
Apr 29, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ERNA Common Stock Options Exercise +438 +65.47% 1.11K Jun 21, 2023 Direct F1
transaction ERNA Common Stock Tax liability -$444 -179 -16.17% $2.48 928 Jun 21, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ERNA Restricted Stock Units Options Exercise $0 -438 -33.38% $0.00 874 Jun 21, 2023 Common Stock 438 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit converts into one share of common stock.
F2 On June 21, 2021, the reporting person was granted 1,750 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.